AFFORDABLE CARE ACT ENROLLMENT REMAINS CONSTANT IN RURAL TEXAS
Brent Magers, CEO Texas Tech Physicians

Last week, I was contacted by a reporter from Austin wanting to know how the “rural” area was handling sign-up for the Affordable Care Act (ACA). In other words, what were we doing to encourage people to sign up for health insurance products for next year purchased through the online exchanges created by the ACA? I ignored the rural comment—I know we are in a sparsely populated area of the state that is clearly rural, but I don’t consider Lubbock, with its population of more than 250,000 (just in the city itself), to be rural.
My opinion on the question the reporter posed is that we will have about the same number of people enroll this year as we’ve had before, at least in our region. I don’t know about the rest of the nation—some predict that it is likely that one million to two million fewer people will choose ACA health plans for 2018, compared with 2017. This is said because advertising spending has been reduced, the open enrollment period has been cut in half to 45 days (Nov. 1-Dec. 15), and there are fewer navigators who help people sign up for insurance plans.
But, I know that we still have navigators available through the Larry Combest Center and Community Health Center of Lubbock. I also personally know at least three insurance brokers who will take all the time needed to explain options to people. They get paid a small commission by the two companies that offer insurance on the exchange serving this area and are therefore highly motivated. The insurance broker community is very helpful to folks needing assistance.
It is true that premiums have increased; but, remember that about 80 percent of the people who sign up are expected to qualify for subsidies that will reduce the cost of insurance to $75 a month or less, according to government data. ACA provides subsidies to single people who make up to $48,000 a year and families of four earning up to $98,000.
Recently, Jimmy Williams, Senior Director of Provider and Payor Relations, was able to obtain very specific data on the number of people Texas Tech Physicians served who were covered through the Blue Cross Blue Shield product purchased on the exchange. It is the first time we had seen the data. It was impressive in terms of the total number of people served. Regardless of what one thinks of the ACA and the philosophy behind it, there is no question that a number of people have benefited from the program.
Related Stories
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
TTUHSC Names New Regional Dean for the School of Nursing
Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.
Recent Stories
Abid Brings Hematology Expertise to TTUHSC Oncology Team
Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.
Research Team Studies Cardiovascular Disease Risk in Homeless Population
A team of student researchers from TTUHSC and TTU evaluated differences in CVD risk between men and women experiencing poverty and homelessness in West Texas, a medically underserved region within the TTUHSC service area.
Clinical Trials Provide Access to Latest Cancer Interventions
Beginning in 2008, TTUHSC, through the School of Medicine Pediatric Cancer Research Center in 2025, has conducted multiple phase 1 oncology clinical trials for pediatric and adult cancer patients. These trials will pave new ground for patients now and in the future.
